# Ondansetron

NDC: 68788-7565
Generic name: Ondansetron
Labeler / Manufacturer: Preferred Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, ORALLY DISINTEGRATING
Routes: ORAL
Marketing started: 20191227

FDA application: ANDA090469

## Active ingredients

- ONDANSETRON: 8 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68788-7565"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68788-7565
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=70b48280-ef74-472b-abc3-128962bfcb05